| Patient | Srinivasa Ramanujan |
|---|---|
| Date of birth | 1887-12-22 |
| Identifiers | MRN HR-ET020-SYN-TD; SSN (made up) 000-20-1937 |
| Document date | 1917-01-26 |
| Author | Edmund Ashworth, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Day 12: end of metronidazole and start of paromomycin, blood count, CRP and liver tests, mood and safety review. [S]
Mr. Ramanujan returns at the end of ten days of metronidazole. At the nurse's call on the third day his fever had already broken, and he has had none since. The ache under his right ribs is much less and no longer catches his breath. Metronidazole gave him a metallic taste and some nausea, eased by taking it with food; he finished every dose three days ago and started paromomycin the next day, which has loosened his stools to twice a day. He asked about the capsule shells, which contain gelatin, and after discussion decided to take them as prescribed. He has no numbness or tingling. He met the dietitian and is cooking once a day for two meals. He has seen the counselor twice. He is sleeping better and has returned to his work for a few hours a day. [S]
| Element | Detail |
|---|---|
| Fever | Gone since the third day |
| Metronidazole | Completed; metallic taste and mild nausea |
| Paromomycin | Day 3 of 7; looser stools |
| Support | Dietitian once; counseling twice |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or sweats; appetite returning |
| Gastrointestinal | Positive | Mild right upper quadrant ache; two loose stools a day on paromomycin; no blood |
| Neurological | Negative | No numbness or tingling |
| Respiratory | Negative | No pain on breathing; no cough |
| Psychiatric | Positive | Mood a little better; still lonely; no thoughts of self-harm |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metronidazole 250 mg oral tablet, three tablets (750 mg) three times a day with food for 10 days | Three tablets every 8 hours with food for 10 days | Oral route | 1917-01-14 to 1917-01-23 | completed | S |
| Paromomycin 250 mg oral capsule, two capsules (500 mg) three times a day with meals for 7 days, started the day after metronidazole ends | Two capsules every 8 hours with meals for 7 days | Oral route | 1917-01-24 to 1917-01-30 | completed | S |
| Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet daily | One tablet daily | Oral route | 1917-01-14 | active | S |
| Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeks | One tablet once a week for 8 weeks | Oral route | 1917-01-14 to 1917-03-04 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1917-01-26 | Body height | 165 | cm | S |
| 1917-01-26 | Body weight | 52.6 | kg | S |
| 1917-01-26 | Body mass index (BMI) [Ratio] | 19.3 | kg/m2 | S |
| 1917-01-26 | Systolic blood pressure | 114 | mm[Hg] | S |
| 1917-01-26 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1917-01-26 | Heart rate | 80 | /min | S |
| 1917-01-26 | Respiratory rate | 16 | /min | S |
| 1917-01-26 | Body temperature | 36.8 | Cel | S |
| 1917-01-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1917-01-26 | Leukocytes [#/volume] in Blood by Automated count | 8.9 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1917-01-26 | Hemoglobin [Mass/volume] in Blood | 11.6 | g/dL | 13.2-17.1 g/dL | Low | S |
| 1917-01-26 | Platelets [#/volume] in Blood by Automated count | 380 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1917-01-26 | C reactive protein [Mass/volume] in Serum or Plasma | 24 | mg/L | <=5 mg/L | High | S |
| 1917-01-26 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 168 | U/L | 40-129 U/L | High | S |
| 1917-01-26 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 34 | U/L | 7-41 U/L | Normal | S |
| 1917-01-26 | Albumin [Mass/volume] in Serum or Plasma | 3.5 | g/dL | 3.5-5 g/dL | Normal | S |
| 1917-01-26 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 10 | {score} | S | ||
| 1917-01-26 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 7 | {score} | S |
Vital signs recorded on 1917-01-26; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Better; temperature 36.8 °C, pulse 80; weight 52.6 kg |
| Respiratory | Breath sounds better at the right base |
| Abdomen | Liver edge 2 cm below the costal margin, mildly tender; less intercostal tenderness |
| Psychiatric | Quieter than most patients but brighter than at intake |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Evening fevers to 38.6 °C with night sweats for about four weeks | resolved | confirmed | R50.9 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Weight loss of 5 kg over two months (57 to 52 kg), with poor appetite | resolved | confirmed | R63.4 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Dull right upper quadrant pain for three weeks, worse on deep breathing and lying on the right side, with a tender liver edge | resolved | confirmed | R10.11 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Amebic liver abscess: a single 6.2 x 5.4 cm abscess in the right lobe (segment VII) on ultrasound, Entamoeba histolytica antibody positive, blood cultures negative, years after two episodes of dysentery in India; treated with metronidazole and then paromomycin; synthetic modern diagnosis linked to the hepatic amoebiasis later proposed for his illness | active | confirmed | A06.4 | S — Synthetic modern diagnosis; it does not settle the historical diagnostic conflict (CLM-0010, CLM-0011). |
| Vitamin B12 deficiency from a strict vegetarian diet (B12 168 pg/mL), with anemia (hemoglobin 11.2 g/dL, MCV 99 fL) to which inflammation also contributes | active | confirmed | D51.3 | S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed. |
| Vitamin D deficiency (25-hydroxyvitamin D 9 ng/mL) | active | confirmed | E55.9 | S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed. |
| Positive interferon-gamma release assay, with chest radiograph and sputum smears and NAAT negative for tuberculosis; cultures pending | active | confirmed | R76.12 | S — Synthetic finding, superseded by the diagnosis of latent infection when cultures were negative. |
| Adjustment disorder with depressed mood (PHQ-9 12, no thoughts of self-harm) during a serious illness, far from his wife and family | active | confirmed | F43.21 | S — Synthetic modern diagnosis anchored to his documented loneliness; not a claim about his real mental health. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Temperature, symptoms and abdominal examination (liver tenderness, right lower rib tenderness) | Every visit | Completed today | Afebrile since day 3; liver less tender |
| Examination | Weight and BMI | Every visit | Completed today | 52.6 kg |
| Laboratory | Blood count and C-reactive protein | At diagnosis, at the end of the tissue course, then until normal | Completed today | White cells 8.9, hemoglobin 11.6, platelets 380; CRP 24 mg/L |
| Laboratory | Liver tests (alkaline phosphatase, ALT, AST, bilirubin, albumin) | At diagnosis, at the end of therapy, and before and during rifampin | Completed today | Alkaline phosphatase 168, ALT 34 U/L; albumin 3.5 g/dL |
| Imaging | Liver imaging | At diagnosis; repeat only for no response or a complication | Not indicated | Clinical response; imaging lags behind recovery and is not repeated |
| Laboratory | Sputum acid-fast smears, NAAT and mycobacterial cultures | Three samples at baseline; cultures final at 6 to 8 weeks | Up to date | Smears and NAAT negative; cultures no growth so far |
| Medication safety | Amebicide safety and completion (nausea, metallic taste, numbness on metronidazole; diarrhea on paromomycin; no overlap) | At the start and every visit during treatment | Completed today | Metronidazole completed with a metallic taste and mild nausea; no numbness; paromomycin day 3 with loose stools; no overlap |
| Laboratory | Response to vitamin B12 replacement | Reticulocyte count at 1 week; blood count at about 8 weeks; neurologic examination at diagnosis | Deferred | Missed: the reticulocyte count one week after starting B12 was not ordered. No harm judging by the rising hemoglobin today (11.6 from 11.2 g/dL) and a normal neurologic examination. Corrective action: none needed for this course; the blood count at about eight weeks confirms the response, and the replacement order set now includes the reticulocyte count |
| Self-management | Diet and weight plan within his vegetarian rules | Every visit | Completed today | Dietitian plan in use; cooking once a day for two meals |
| Survey | PHQ-9 and GAD-7 | At least monthly while symptoms are active | Completed today | PHQ-9 10, GAD-7 7 |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current |
| Self-management | Support far from home (counseling, contact with family and community, department and fellowship) | Every visit | Completed today | Counseling twice; weekly call home planned; back at work part of the day |
Goal progress:
Guideline basis: Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017); DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026); A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis (2018); Position of the Academy of Nutrition and Dietetics: Vegetarian Diets (2016); CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Review at six weeks with the final sputum cultures, blood count, liver tests, vitamin B12 and mood. Call for fever, return of the right-sided pain, or diarrhea that does not settle after paromomycin. Next scheduled visit 1917-02-23: six weeks: recovery, final sputum cultures, liver tests before rifampin, vitamin B12, mood, influenza vaccine. [S]